Condition
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) clinical trials that are recruiting, at sites in 5 countries (most in United States (2), Czechia (1), Poland (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Weekly subcutaneous XEMBIFY versus every-3-week intravenous Gamunex-C for CIDP
This will test whether weekly under-the-skin XEMBIFY gives similar blood IgG levels as Gamunex-C given into a vein every three weeks in people with CIDP.
-
Real-world efgartigimod use in adults with CIDP
This study will see if efgartigimod helps adults with CIDP when given as part of routine clinical care.
Related topics
Quick answers
How many CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Czechia (1 trial), Poland (1 trial), Romania (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.